Hanning Hu
- Topics
- SARS-CoV-2 and COVID-19 Research (3 papers)COVID-19 Clinical Research Studies (3 papers)SARS-CoV-2 detection and testing (2 papers)
- Cited by
- Infectious DiseasesHealthImmunology
- Journals
- Biochemical and Biophysical Research CommunicationsThe Lancet Infectious DiseasesMolecular Psychiatry
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Hanning Hu
14 papers receiving 652 citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Infectious Diseases 398
- Molecular Biology 131
- Biomedical Engineering 92
- Immunology 89
- Epidemiology 86
Countries citing papers authored by Hanning Hu
This map shows the geographic impact of Hanning Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanning Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanning Hu more than expected).
Fields of papers citing papers by Hanning Hu
This network shows the impact of papers produced by Hanning Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanning Hu. The network helps show where Hanning Hu may publish in the future.
Co-authorship network of co-authors of Hanning Hu
This figure shows the co-authorship network connecting the top 25 collaborators of Hanning Hu. A scholar is included among the top collaborators of Hanning Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanning Hu. Hanning Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trialbreakdown → | 192 |
| 3 | 25 | |
| 4 | 30 | |
| 5 | 255 | |
| 6 | 8 | |
| 7 | 17 | |
| 8 | 9 | |
| 9 | 22 | |
| 10 | 13 | |
| 11 | 15 | |
| 12 | 70 | |
| 13 | 6 | |
| 14 | Association of the TaqIB polymorphism and D442G mutation of cholesteryl ester transfer protein gene with coronary heart disease | 4 |
About Hanning Hu
Hanning Hu is a scholar working on Nephrology, Infectious Diseases and Neurology, having authored 14 papers that have together received 668 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), COVID-19 Clinical Research Studies (3 papers) and SARS-CoV-2 detection and testing (2 papers). The work is most often cited by research in Infectious Diseases (398 citations), Health (39 citations) and Immunology (89 citations). Hanning Hu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Junli Fan, Xue Han, Gui Yang, Xinran Li, Yinjuan Liu, Yueting Tang, Yirong Li, Xinghua Long, Shuang Guo and Yunbao Pan. Their work appears in journals such as Biochemical and Biophysical Research Communications, The Lancet Infectious Diseases and Molecular Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.